Dr. Agarwal's Health Care Limited (BOM:544350)
India flag India · Delayed Price · Currency is INR
479.10
-2.40 (-0.50%)
At close: Jul 31, 2026

Dr. Agarwal's Health Care Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
1,332834.6830.6940.97376.94
Depreciation & Amortization
2,7622,3031,6991,235871.07
Other Amortization
-19.74.948.168.5
Loss (Gain) From Sale of Assets
-0.34.3-1.9-0.42.36
Asset Writedown & Restructuring Costs
-30.2--37.03
Loss (Gain) From Sale of Investments
-144.1-171.3-246.7-46.62-
Stock-Based Compensation
73.983.850.618.26-
Provision & Write-off of Bad Debts
224.4148.5112.2117.54111
Other Operating Activities
1,4201,294965.1143.4326.49
Change in Accounts Receivable
-541.2-436.4-292.4-313.69-211.05
Change in Inventory
-137.6-264.8-152.8-24.92-46.89
Change in Accounts Payable
-266360.7128.93168.57
Change in Other Net Operating Assets
200.9-508.1130.984.63-60.74
Operating Cash Flow
5,1903,6033,4602,3311,643
Operating Cash Flow Growth
44.03%4.14%48.43%41.85%65.72%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-4,480-3,087-2,309-1,566-702.39
Sale of Property, Plant & Equipment
8.65.342.55.038.11
Cash Acquisitions
-913.4-5,158-2,867-3,208-797.06
Sale (Purchase) of Intangibles
-126.3-122.5-14.2-12.28-3.49
Investment in Securities
1,2582,239-4,122-289.98-
Other Investing Activities
1,168-1,381130.6-20.12-58.68
Investing Cash Flow
-3,085-7,503-9,139-5,091-1,554

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Long-Term Debt Issued
-615.22,4521,7311,110
Total Debt Issued
-615.22,4521,7311,110
Long-Term Debt Repaid
-2,228-3,015-2,968-1,409-694.66
Total Debt Repaid
-2,228-3,015-2,968-1,409-694.66
Net Debt Issued (Repaid)
-2,228-2,400-515.5321.45415.4
Issuance of Common Stock
113.72,7996,3713,009-
Common Dividends Paid
-10.9-7.9-7.7-4.28-0.07
Other Financing Activities
-79.1-368.8-321.5-292.74-209.25
Financing Cash Flow
-2,2043,8195,5273,033354.33

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Miscellaneous Cash Flow Adjustments
-0.1---
Net Cash Flow
-98.5-81.4-152.3273.6444.1

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
710.4516.81,151765.33940.89
Free Cash Flow Growth
37.46%-55.10%50.38%-18.66%-
Free Cash Flow Margin
3.42%3.02%8.64%7.52%13.52%
Free Cash Flow Per Share
2.231.724.343.254.57
Levered Free Cash Flow
-377.46-534.71395.88584.17533.38
Unlevered Free Cash Flow
187.91139.41993.51,034817.12

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
79.1322.4321.5292.74207.67
Cash Income Tax Paid
550.6366320.9353.83155.96
Change in Working Capital
-477.9-943.346.4-125.05-150.11